Application number | Title of the application | Filing Date | Status |
---|
09/485550 | SOLUTIONS CONTAINING AZASTEROIDS | Feb 10, 2000 | Abandoned |
Array
(
[id] => 931239
[patent_doc_number] => 06979743
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-12-27
[patent_title] => 'Processes for preparing phytosterols and substantially citrostadienol-free phytosterols prepared thereby'
[patent_app_type] => utility
[patent_app_number] => 09/913377
[patent_app_country] => US
[patent_app_date] => 2000-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1263
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/979/06979743.pdf
[firstpage_image] =>[orig_patent_app_number] => 09913377
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/913377 | Processes for preparing phytosterols and substantially citrostadienol-free phytosterols prepared thereby | Feb 3, 2000 | Issued |
Array
(
[id] => 1545780
[patent_doc_number] => 06444660
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-03
[patent_title] => 'Lipid soluble steroid prodrugs'
[patent_app_type] => B1
[patent_app_number] => 09/496761
[patent_app_country] => US
[patent_app_date] => 2000-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54292
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/444/06444660.pdf
[firstpage_image] =>[orig_patent_app_number] => 09496761
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/496761 | Lipid soluble steroid prodrugs | Feb 2, 2000 | Issued |
Array
(
[id] => 4304416
[patent_doc_number] => 06187763
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-13
[patent_title] => 'Activated vitamin D3 emulsion-type lotions'
[patent_app_type] => 1
[patent_app_number] => 9/423230
[patent_app_country] => US
[patent_app_date] => 2000-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3811
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/187/06187763.pdf
[firstpage_image] =>[orig_patent_app_number] => 423230
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/423230 | Activated vitamin D3 emulsion-type lotions | Jan 31, 2000 | Issued |
Array
(
[id] => 4346235
[patent_doc_number] => 06284750
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-04
[patent_title] => '.alpha.-hydroxyacid esters of DHEA useful against skin disorders'
[patent_app_type] => 1
[patent_app_number] => 9/491710
[patent_app_country] => US
[patent_app_date] => 2000-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6155
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/284/06284750.pdf
[firstpage_image] =>[orig_patent_app_number] => 491710
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/491710 | .alpha.-hydroxyacid esters of DHEA useful against skin disorders | Jan 25, 2000 | Issued |
09/403702 | USE OF ANABOLIC STEROID DERIVATIVES IN THE TREATMENT OF CHRONIC HEART FAILURE | Jan 24, 2000 | Abandoned |
Array
(
[id] => 1567801
[patent_doc_number] => 06376687
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-23
[patent_title] => 'Steroid sulfatase inhibitors and methods for making and using the same'
[patent_app_type] => B1
[patent_app_number] => 09/490302
[patent_app_country] => US
[patent_app_date] => 2000-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10219
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/376/06376687.pdf
[firstpage_image] =>[orig_patent_app_number] => 09490302
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/490302 | Steroid sulfatase inhibitors and methods for making and using the same | Jan 23, 2000 | Issued |
Array
(
[id] => 4133971
[patent_doc_number] => 06121279
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-19
[patent_title] => 'Substituted 6-phenylphenanthridines'
[patent_app_type] => 1
[patent_app_number] => 9/462508
[patent_app_country] => US
[patent_app_date] => 2000-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8062
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 300
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/121/06121279.pdf
[firstpage_image] =>[orig_patent_app_number] => 462508
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/462508 | Substituted 6-phenylphenanthridines | Jan 23, 2000 | Issued |
Array
(
[id] => 6000613
[patent_doc_number] => 20020028793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-07
[patent_title] => 'Use of estrogens and delta-gonadien-21-3,20-diones'
[patent_app_type] => new
[patent_app_number] => 09/484673
[patent_app_country] => US
[patent_app_date] => 2000-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5577
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20020028793.pdf
[firstpage_image] =>[orig_patent_app_number] => 09484673
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/484673 | Use of estrogens and delta-gonadien-21-3,20-diones | Jan 17, 2000 | Abandoned |
Array
(
[id] => 1596255
[patent_doc_number] => 06384228
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-05-07
[patent_title] => 'Method for synthesis of halopyridyl-azacyclopentane derivative and intermediate thereof'
[patent_app_type] => B2
[patent_app_number] => 09/462379
[patent_app_country] => US
[patent_app_date] => 2000-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8839
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/384/06384228.pdf
[firstpage_image] =>[orig_patent_app_number] => 09462379
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/462379 | Method for synthesis of halopyridyl-azacyclopentane derivative and intermediate thereof | Jan 6, 2000 | Issued |
Array
(
[id] => 1216742
[patent_doc_number] => 06706701
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-16
[patent_title] => '6, 7-oxygenated steroids and uses related thereto'
[patent_app_type] => B1
[patent_app_number] => 09/471827
[patent_app_country] => US
[patent_app_date] => 1999-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50623
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 346
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/706/06706701.pdf
[firstpage_image] =>[orig_patent_app_number] => 09471827
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/471827 | 6, 7-oxygenated steroids and uses related thereto | Dec 22, 1999 | Issued |
Array
(
[id] => 7029010
[patent_doc_number] => 20010014748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-16
[patent_title] => 'HIV INTEGRASE INHIBITORS'
[patent_app_type] => new
[patent_app_number] => 09/459840
[patent_app_country] => US
[patent_app_date] => 1999-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14813
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20010014748.pdf
[firstpage_image] =>[orig_patent_app_number] => 09459840
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/459840 | HIV integrase inhibitors | Dec 12, 1999 | Issued |
09/319673 | PROCESSES FOR PREPARATION OF 9,11-EPOXY STEROIDS AND INTERMEDIATES USEFUL THEREIN | Dec 12, 1999 | Abandoned |
Array
(
[id] => 1548614
[patent_doc_number] => 06346259
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-02-12
[patent_title] => 'Method for preparing of betaine alkyl ester mixture'
[patent_app_type] => B1
[patent_app_number] => 09/458992
[patent_app_country] => US
[patent_app_date] => 1999-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3269
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/346/06346259.pdf
[firstpage_image] =>[orig_patent_app_number] => 09458992
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/458992 | Method for preparing of betaine alkyl ester mixture | Dec 9, 1999 | Issued |
Array
(
[id] => 7029037
[patent_doc_number] => 20010014749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-16
[patent_title] => 'THERAPEUTICALLY EFFECTIVE 1ALPHA,25-DIHYDROXYVITAMIN D3 ANALOGS'
[patent_app_type] => new
[patent_app_number] => 09/452282
[patent_app_country] => US
[patent_app_date] => 1999-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 29198
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20010014749.pdf
[firstpage_image] =>[orig_patent_app_number] => 09452282
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/452282 | Therapeutically effective 1.alpha., 25-dihydroxyvitamin D3 analogs | Nov 29, 1999 | Issued |
09/449042 | USE OF 17-KETOSTEROID COMPOUNDS AND DERIVATIVES, METABOLITES AND PRECURSORS THEREOF IN TREATMENT OF TOXOPLASMOSIS AND IN THE TREATMENT OF CRYPTOSPORIDIOSIS | Nov 23, 1999 | Abandoned |
Array
(
[id] => 1281659
[patent_doc_number] => 06642220
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-04
[patent_title] => 'Compounds that inhibit oestrone sulphatase; compositions thereof; and methods employing the same'
[patent_app_type] => B1
[patent_app_number] => 09/319213
[patent_app_country] => US
[patent_app_date] => 1999-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 17
[patent_no_of_words] => 6350
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/642/06642220.pdf
[firstpage_image] =>[orig_patent_app_number] => 09319213
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/319213 | Compounds that inhibit oestrone sulphatase; compositions thereof; and methods employing the same | Nov 22, 1999 | Issued |
Array
(
[id] => 6243605
[patent_doc_number] => 20020045773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-18
[patent_title] => 'PROCESS FOR THE PREPARATION OF STANOL ESTERS'
[patent_app_type] => new
[patent_app_number] => 09/367836
[patent_app_country] => US
[patent_app_date] => 1999-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3130
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20020045773.pdf
[firstpage_image] =>[orig_patent_app_number] => 09367836
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/367836 | PROCESS FOR THE PREPARATION OF STANOL ESTERS | Nov 21, 1999 | Abandoned |
09/436810 | METHOD OF STIMULATING MEIOSIS | Nov 8, 1999 | Abandoned |
09/436610 | METHODS FOR INHIBITING ANGIOGENESIS WITH 2-METHOXYESTRADIOL | Nov 8, 1999 | Abandoned |